Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China

por Gu, Shuyan, Zeng, Yuhang, Yu, Demin, Hu, Xiaoqian, Dong, Hengjin
Publicado 2016

Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: A Multicenter Study...

por Zhen, Xuemei, Stålsby Lundborg, Cecilia, Sun, Xueshan, Gu, Shuyan, Dong, Hengjin
Publicado 2020

Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China

por Gu, Shuyan, Mu, Yiming, Zhai, Suodi, Zeng, Yuhang, Zhen, Xuemei, Dong, Hengjin
Publicado 2016

Trends in Cognitive Function Among Chinese Elderly From 1998 to 2018: An Age-Period-Cohort Analysis

por Hu, Xiaoqian, Gu, Shuyan, Zhen, Xuemei, Sun, Xueshan, Gu, Yuxuan, Dong, Hengjin
Publicado 2021

Trends in activities of daily living disability among Chinese older adults from 1998 to 2018: an age-period-cohort analysis

por Hu, Xiaoqian, Gu, Shuyan, Zhen, Xuemei, Sun, Xueshan, Gu, Yuxuan, Dong, Hengjin
Publicado 2022

Economic burden of antibiotic resistance in China: a national level estimate for inpatients

por Zhen, Xuemei, Stålsby Lundborg, Cecilia, Sun, Xueshan, Zhu, Nina, Gu, Shuyan, Dong, Hengjin
Publicado 2021

Correction to: Economic burden of antibiotic resistance in China: a national level estimate for inpatients

por Zhen, Xuemei, Lundborg, Cecilia Stålsby, Sun, Xueshan, Zhu, Nina, Gu, Shuyan, Dong, Hengjin
Publicado 2021

Cognitive and physical function of people older than 80 years in China from 1998 to 2014

por Hu, Xiaoqian, Zeng, Yuhang, Zhen, Xuemei, Zhang, Hao, Li, Yuanyuan, Gu, Shuyan, Dong, Hengjin
Publicado 2018

Osteoarthritis in the Middle-Aged and Elderly in China: Prevalence and Influencing Factors

por Sun, Xueshan, Zhen, Xuemei, Hu, Xiaoqian, Li, Yuanyuan, Gu, Shuyan, Gu, Yuxuan, Dong, Hengjin
Publicado 2019

Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis

por Gu, Shuyan, Shi, Lizheng, Shao, Hui, Wang, Xiaoyong, Hu, Xiaoqian, Gu, Yuxuan, Dong, Hengjin
Publicado 2020

The Impact of Disability on Intergenerational Care Needs of the Elderly in China

por Bai, Lan, Gu, Shuyan, Gu, Hai, Xu, Xinpeng, Nan, Cui, Li, Decheng, Di, Wu
Publicado 2021

Comparison of Glucose Lowering Effect of Metformin and Acarbose in Type 2 Diabetes Mellitus: A Meta-Analysis

por Gu, Shuyan, Shi, Jihao, Tang, Zhiliu, Sawhney, Monika, Hu, Huimei, Shi, Lizheng, Fonseca, Vivian, Dong, Hengjin
Publicado 2015

LncRNA FEZF1-AS1 Promotes TGF-β2-Mediated Proliferation and Migration in Human Lens Epithelial Cells SRA01/04

por Wang, Yong, Chen, Lili, Gu, Yonghui, Wang, Ying, Yuan, You, Zhu, Qiujian, Bi, Mingchao, Gu, Shuyan
Publicado 2019

Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis

por Gu, Shuyan, Hu, Xiaoqian, Shi, Lizheng, Zhen, Xuemei, Sun, Xueshan, Huang, Minzhuo, Gu, Yuxuan, Dong, Hengjin
Publicado 2022

Measurement and analysis of equity in health: a case study conducted in Zhejiang Province, China

por Sun, Xueshan, Zhang, Hao, Hu, Xiaoqian, Gu, Shuyan, Zhen, Xuemei, Gu, Yuxuan, Huang, Minzhuo, Wei, Jingming, Dong, Hengjin
Publicado 2018

Potential gains in health-adjusted life expectancy from reducing four main non-communicable diseases among Chinese elderly

por Hu, Xiaoqian, Sun, Xueshan, Li, Yuanyuan, Gu, Yuxuan, Huang, Minzhuo, Wei, Jingming, Zhen, Xuemei, Gu, Shuyan, Dong, Hengjin
Publicado 2019

Outpatient health-seeking behavior of residents in Zhejiang and Qinghai Province, China

por Huang, Minzhuo, Zhang, Hao, Gu, Yuxuan, Wei, Jingming, Gu, Shuyan, Zhen, Xuemei, Hu, Xiaoqian, Sun, Xueshan, Dong, Hengjin
Publicado 2019

Comparison of Glucose-Lowering Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis

por Gu, Shuyan, Hu, Xiaoqian, Zhen, Xuemei, Shi, Lizheng, Shao, Hui, Sun, Xueshan, Gu, Yuxuan, Huang, Minzhuo, Dong, Hengjin
Publicado 2022

Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis

por Sun, Xueshan, Zhen, Xuemei, Hu, Xiaoqian, Li, Yuanyuan, Gu, ShuYan, Gu, Yuxuan, Zhao, Zixuan, Yang, Wei, Dong, Hengjin
Publicado 2021

A comparative study of catastrophic health expenditure in Zhejiang and Qinghai province, China

por Zhen, Xuemei, Zhang, Hao, Hu, Xiaoqian, Gu, Shuyan, Li, Yuanyuan, Gu, Yuxuan, Huang, Minzhuo, Sun, Xueshan, Wei, Jingming, Dong, Hengjin
Publicado 2018